These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10650809)

  • 1. An immunohistochemical analysis of angiogenesis in invasive breast cancer with correlations to clinicopathologic predictors.
    Nakopoulou L; Lekkas N; Lazaris AC; Athanassiadou P; Giannopoulou I; Mavrommatis J; Davaris P
    Anticancer Res; 1999; 19(5C):4547-53. PubMed ID: 10650809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma.
    Olewniczak S; Chosia M; Kołodziej B; Kwas A; Kram A; Domagała W
    Pol J Pathol; 2003; 54(1):53-9. PubMed ID: 12817881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COX-2 expression does not correlate with microvessel density in breast cancer.
    Thorat MA; Mehrotra S; Morimiya A; Badve S
    Pathobiology; 2009; 76(1):39-44. PubMed ID: 19188749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
    Siitonen SM; Haapasalo HK; Rantala IS; Helin HJ; Isola JJ
    Mod Pathol; 1995 Sep; 8(7):745-52. PubMed ID: 8539232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast.
    Morphopoulos G; Pearson M; Ryder WD; Howell A; Harris M
    J Pathol; 1996 Sep; 180(1):44-9. PubMed ID: 8943814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of periductal lymphatic and blood vascular densities in intraductal carcinoma of the breast.
    El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
    Breast J; 2009; 15(3):261-7. PubMed ID: 19645781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma.
    Imai J; Ghazizadeh M; Naito Z; Asano G
    Anticancer Res; 2001; 21(2B):1327-34. PubMed ID: 11396208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients.
    Hansen S; Grabau DA; Sørensen FB; Bak M; Vach W; Rose C
    Clin Cancer Res; 2000 Jan; 6(1):139-46. PubMed ID: 10656442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women.
    Olewniczak S; Chosia M; Kwas A; Kram A; Domagała W
    Pol J Pathol; 2002; 53(4):183-8. PubMed ID: 12597334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
    Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
    J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
    Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
    Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis.
    Jacquemier JD; Penault-Llorca FM; Bertucci F; Sun ZZ; Houvenaeghel GF; Geneix JA; Puig BD; Bardou VJ; Hassoun JA; Birnbaum D; Viens PJ
    J Pathol; 1998 Feb; 184(2):130-5. PubMed ID: 9602702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast.
    Sapino A; Bongiovanni M; Cassoni P; Righi L; Arisio R; Deaglio S; Malavasi F
    J Pathol; 2001 Jun; 194(2):254-61. PubMed ID: 11400156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival.
    Campo L; Turley H; Han C; Pezzella F; Gatter KC; Harris AL; Fox SB
    J Pathol; 2005 Apr; 205(5):585-91. PubMed ID: 15776477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer.
    Su MY; Cheung YC; Fruehauf JP; Yu H; Nalcioglu O; Mechetner E; Kyshtoobayeva A; Chen SC; Hsueh S; McLaren CE; Wan YL
    J Magn Reson Imaging; 2003 Oct; 18(4):467-77. PubMed ID: 14508784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
    Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
    Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
    MacConmara M; O'Hanlon DM; Kiely MJ; Connolly Y; Jeffers M; Keane FB
    Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.